Literature DB >> 8528677

Dopamine increases renal medullary blood flow without improving regional hypoxia.

S N Heyman1, N Kaminski, M Brezis.   

Abstract

The effects of dopamine (10 micrograms/kg/min i.v.) upon intrarenal microcirculation, total, superficial cortical and outer medullary blood flows and outer medullary pO2 were continuously determined in anesthetized rats with ultrasonic and laser-Doppler probes and oxygen microelectrodes. While total and cortical flows were unaffected, outer medullary flow increased by 35 +/- 5% (mean +/- SE, p < 0.01). Outer medullary pO2 was not significantly altered (from 16 +/- 4 to 18 +/- 4 mm Hg). In volume-expanded rats total and cortical flows rose as well. In rats pretreated with indomethacin, with or without N omega-nitro-L-arginine methyl ester HCl, dopamine restored renal microcirculation and ameliorated outer medullary hypoxia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8528677

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  5 in total

Review 1.  An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure.

Authors:  M K Dishart; J A Kellum
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

Review 2.  Functional MRI of the kidney: tools for translational studies of pathophysiology of renal disease.

Authors:  Pottumarthi V Prasad
Journal:  Am J Physiol Renal Physiol       Date:  2006-05

Review 3.  Blood oxygen level-dependent MR imaging of the kidneys.

Authors:  Lu-Ping Li; Sarah Halter; Pottumarthi V Prasad
Journal:  Magn Reson Imaging Clin N Am       Date:  2008-11       Impact factor: 2.266

Review 4.  Moving beyond supportive care--current status of specific therapies in pediatric acute kidney injury.

Authors:  Jordan M Symons
Journal:  Pediatr Nephrol       Date:  2013-02-14       Impact factor: 3.714

5.  The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence.

Authors: 
Journal:  Crit Care       Date:  1997       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.